ID HEXA_BOVIN Reviewed; 529 AA. AC Q0V8R6; DT 06-FEB-2007, integrated into UniProtKB/Swiss-Prot. DT 05-SEP-2006, sequence version 1. DT 27-MAR-2024, entry version 122. DE RecName: Full=Beta-hexosaminidase subunit alpha {ECO:0000250|UniProtKB:P06865}; DE EC=3.2.1.52 {ECO:0000250|UniProtKB:P06865}; DE AltName: Full=Beta-N-acetylhexosaminidase subunit alpha; DE Short=Hexosaminidase subunit A; DE AltName: Full=N-acetyl-beta-glucosaminidase subunit alpha; DE Flags: Precursor; GN Name=HEXA {ECO:0000250|UniProtKB:P06865}; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=16305752; DOI=10.1186/1471-2164-6-166; RA Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L., RA Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.; RT "Characterization of 954 bovine full-CDS cDNA sequences."; RL BMC Genomics 6:166-166(2005). CC -!- FUNCTION: Hydrolyzes the non-reducing end N-acetyl-D-hexosamine and/or CC sulfated N-acetyl-D-hexosamine of glycoconjugates, such as the CC oligosaccharide moieties from proteins and neutral glycolipids, or from CC certain mucopolysaccharides. The isozyme S is as active as the isozyme CC A on the anionic bis-sulfated glycans, the chondroitin-6-sulfate CC trisaccharide (C6S-3), and the dermatan sulfate pentasaccharide, and CC the sulfated glycosphingolipid SM2. The isozyme B does not hydrolyze CC each of these substrates, however hydrolyzes efficiently neutral CC oligosaccharide. Only the isozyme A is responsible for the degradation CC of GM2 gangliosides in the presence of GM2A. CC {ECO:0000250|UniProtKB:P06865}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Hydrolysis of terminal non-reducing N-acetyl-D-hexosamine CC residues in N-acetyl-beta-D-hexosaminides.; EC=3.2.1.52; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-3- CC sulfogalactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide = a beta-D- CC 3-sulfogalactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide + N- CC acetyl-beta-D-galactosamine; Xref=Rhea:RHEA:48276, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:28497, ChEBI:CHEBI:90163, ChEBI:CHEBI:90164; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48277; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a ganglioside GM2 (d18:1(4E)) + H2O = a ganglioside GM3 CC (d18:1(4E)) + N-acetyl-beta-D-galactosamine; Xref=Rhea:RHEA:47940, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:28497, ChEBI:CHEBI:60065, CC ChEBI:CHEBI:71502; Evidence={ECO:0000250|UniProtKB:P06865}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47941; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a ganglioside GM2 + H2O = a ganglioside GM3 + N-acetyl-beta-D- CC galactosamine; Xref=Rhea:RHEA:47968, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:28497, ChEBI:CHEBI:79210, ChEBI:CHEBI:79218; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47969; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-GalNAc-(1->4)-alpha-L-IdoA-(1->3)-beta-D-GalNAc-4- CC sulfate-(1->4)-alpha-L-IdoA-(1->3)-D-GalNAc-4-sulfate + H2O = alpha- CC L-IdoA-(1->3)-beta-D-GalNAc-4-sulfate-(1->4)-alpha-L-IdoA-(1->3)-D- CC GalNAc-4-sulfate + N-acetyl-D-galactosamine; Xref=Rhea:RHEA:64372, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:28037, ChEBI:CHEBI:152565, CC ChEBI:CHEBI:152566; Evidence={ECO:0000250|UniProtKB:P06865}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64373; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + N-acetyl-beta-D-6-sulfogalactosaminyl-(1->4)-alpha-L- CC iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine = alpha-L-iduronyl- CC (1->3)-N-acetyl-D-6-sulfogalactosamine + N-acetyl-D-6- CC sulfogalactosamine; Xref=Rhea:RHEA:64384, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:152567, ChEBI:CHEBI:152568, ChEBI:CHEBI:153064; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64385; CC Evidence={ECO:0000250|UniProtKB:P06865}; CC -!- ACTIVITY REGULATION: Addition of GM2A stimulates the hydrolysis of CC sulfated glycosphingolipid SM2 and the ganglioside GM2. CC {ECO:0000250|UniProtKB:P06865}. CC -!- SUBUNIT: There are 3 beta-hexosaminidase isozymes: isozyme A CC (hexosaminidase A) is an heterodimer composed of one subunit alpha and CC one subunit beta (chain A and B); isozyme B (hexosaminidase B) is an CC homodimer of two beta subunits (two chains A and B); isozyme S CC (hexosaminidase S) is a homodimer of two alpha subunits. The CC composition of the dimer (isozyme A versus isozyme S) has a significant CC effect on the substrate specificity of the alpha subunit active site. CC {ECO:0000250|UniProtKB:P06865}. CC -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000250}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 20 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BT026152; ABG66991.1; -; mRNA. DR RefSeq; NP_001068632.1; NM_001075164.2. DR AlphaFoldDB; Q0V8R6; -. DR SMR; Q0V8R6; -. DR STRING; 9913.ENSBTAP00000017261; -. DR BindingDB; Q0V8R6; -. DR ChEMBL; CHEMBL1075052; -. DR CAZy; GH20; Glycoside Hydrolase Family 20. DR GlyCosmos; Q0V8R6; 3 sites, No reported glycans. DR PaxDb; 9913-ENSBTAP00000017261; -. DR Ensembl; ENSBTAT00000017261.4; ENSBTAP00000017261.3; ENSBTAG00000012981.4. DR GeneID; 504468; -. DR KEGG; bta:504468; -. DR CTD; 3073; -. DR VEuPathDB; HostDB:ENSBTAG00000012981; -. DR VGNC; VGNC:112630; HEXA. DR eggNOG; KOG2499; Eukaryota. DR GeneTree; ENSGT00390000008107; -. DR HOGENOM; CLU_007082_0_3_1; -. DR InParanoid; Q0V8R6; -. DR OMA; KMWPRAA; -. DR OrthoDB; 178991at2759; -. DR TreeFam; TF313036; -. DR BRENDA; 3.2.1.52; 908. DR Reactome; R-BTA-2022857; Keratan sulfate degradation. DR Reactome; R-BTA-2024101; CS/DS degradation. DR Reactome; R-BTA-2160916; Hyaluronan uptake and degradation. DR Reactome; R-BTA-9840310; Glycosphingolipid catabolism. DR PRO; PR:Q0V8R6; -. DR Proteomes; UP000009136; Chromosome 10. DR Bgee; ENSBTAG00000012981; Expressed in uterine cervix and 104 other cell types or tissues. DR GO; GO:0042582; C:azurophil granule; IEA:Ensembl. DR GO; GO:1905379; C:beta-N-acetylhexosaminidase complex; IEA:Ensembl. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0005764; C:lysosome; IBA:GO_Central. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0008375; F:acetylglucosaminyltransferase activity; IEA:Ensembl. DR GO; GO:0004563; F:beta-N-acetylhexosaminidase activity; ISS:UniProtKB. DR GO; GO:0102148; F:N-acetyl-beta-D-galactosaminidase activity; IEA:UniProtKB-EC. DR GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl. DR GO; GO:0007628; P:adult walking behavior; IEA:Ensembl. DR GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl. DR GO; GO:0030209; P:dermatan sulfate catabolic process; IEA:Ensembl. DR GO; GO:0006689; P:ganglioside catabolic process; ISS:UniProtKB. DR GO; GO:0006024; P:glycosaminoglycan biosynthetic process; IEA:Ensembl. DR GO; GO:0030203; P:glycosaminoglycan metabolic process; IBA:GO_Central. DR GO; GO:0030214; P:hyaluronan catabolic process; IEA:Ensembl. DR GO; GO:0019915; P:lipid storage; IEA:Ensembl. DR GO; GO:0007040; P:lysosome organization; IEA:Ensembl. DR GO; GO:0051651; P:maintenance of location in cell; IEA:Ensembl. DR GO; GO:0042552; P:myelination; IEA:Ensembl. DR GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl. DR GO; GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl. DR GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl. DR GO; GO:0019953; P:sexual reproduction; IEA:Ensembl. DR GO; GO:0001501; P:skeletal system development; IEA:Ensembl. DR CDD; cd06562; GH20_HexA_HexB-like; 1. DR Gene3D; 3.30.379.10; Chitobiase/beta-hexosaminidase domain 2-like; 1. DR Gene3D; 3.20.20.80; Glycosidases; 1. DR InterPro; IPR025705; Beta_hexosaminidase_sua/sub. DR InterPro; IPR015883; Glyco_hydro_20_cat. DR InterPro; IPR017853; Glycoside_hydrolase_SF. DR InterPro; IPR029018; Hex-like_dom2. DR InterPro; IPR029019; HEX_eukaryotic_N. DR PANTHER; PTHR22600; BETA-HEXOSAMINIDASE; 1. DR PANTHER; PTHR22600:SF39; BETA-HEXOSAMINIDASE SUBUNIT ALPHA; 1. DR Pfam; PF00728; Glyco_hydro_20; 1. DR Pfam; PF14845; Glycohydro_20b2; 1. DR PIRSF; PIRSF001093; B-hxosamndse_ab_euk; 1. DR PRINTS; PR00738; GLHYDRLASE20. DR SUPFAM; SSF51445; (Trans)glycosidases; 1. DR SUPFAM; SSF55545; beta-N-acetylhexosaminidase-like domain; 1. PE 2: Evidence at transcript level; KW Disulfide bond; Glycoprotein; Glycosidase; Hydrolase; Lipid metabolism; KW Lysosome; Reference proteome; Signal; Zymogen. FT SIGNAL 1..22 FT /evidence="ECO:0000250" FT PROPEP 23..88 FT /evidence="ECO:0000250" FT /id="PRO_0000274203" FT CHAIN 89..529 FT /note="Beta-hexosaminidase subunit alpha" FT /id="PRO_0000274204" FT REGION 423..424 FT /note="Critical for hydrolysis GM2 gangliosides" FT /evidence="ECO:0000250" FT ACT_SITE 323 FT /note="Proton donor" FT /evidence="ECO:0000250" FT CARBOHYD 115 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 157 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 295 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 58..104 FT /evidence="ECO:0000250" FT DISULFID 277..328 FT /evidence="ECO:0000250" FT DISULFID 505..522 FT /evidence="ECO:0000250" SQ SEQUENCE 529 AA; 60353 MW; 878641B502FCD3A9 CRC64; MAGSTLRFSL LLAAAFAGRA TALWPWPQYI QTSELRYTIF PQSFQFQYHL SSAAQVGCSV LDEAFQRYRD LLFGSVAFRF PHPIEKRHTS EKNSLVVLVV TPGCDQFPSL GSVENYTLTI NDEQSLLLSE TVWGALRGLE TFSQLIWRSP EGTFYVNKTD IEDFPRFPHR GLLLDTSRHY LPLASILDTL DVMAYNKFNV FHWHLVDDSS FPYESFTFPE LTKKGSYNPA THIYTAQDVK EVIEYARLRG IRVLAEFDTP GHTLSWGPGV PGLLTPCYSG SHPSGTFGPV NPALNNTYEF MSTFFLEIST VFPDFYLHLG GDEVDFTCWK SNPDIQAFMK KKGFGDDFKK LESFYIQTLL DIVSAYGKGY VVWQEVFDNK VKVRPDTIIQ VWREEIPVKY VKELALVTRA GFRALLSAPW YLNHITYGPD WKEIYLVEPL AFEGSPEQKA LVIGGEACMW GEYVDSTNLV PRLWPRAGAV AERLWSNKMV SNLDFAFKRL AHFRCELLRR GVQAQPLSVG YCDMEFEQT //